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Abstract 
 
Objective: A strong genetic predisposition for type 2 diabetes mellitus (T2DM) may aggravate 
the negative effects of low socioeconomic position (SEP) in the etiology of the disorder. This 
study aimed to examine cross-sectional and longitudinal associations and interactions of a 
genetic risk score (GRS) and SEP with T2DM, and to investigate whether clinical and behavioral 
risk factors can explain these associations and interactions.  
 
Methods: We used data from 13,027 genotyped participants from the Lifelines study. The GRS 
was based on single-nucleotide polymorphisms (SNPs) genome-wide associated with T2DM and 
was categorized into tertiles. SEP was measured as educational level. T2DM was based on 
biological markers, recorded medication use, and self-reports. Cross-sectional and longitudinal 
associations, and interactions, between the GRS and SEP on T2DM were examined.  
 
Results: The combination of a high GRS and low SEP had the strongest association with T2DM 
in cross-sectional (OR: 3.84; 95% CI: 2.28, 6.46) and longitudinal analyses (HR: 2.71; 1.39, 
5.27), compared to a low GRS and high SEP. Interaction between a high GRS and a low SEP 
was observed in cross-sectional (relative excess risk due to interaction: 1.85; 0.65, 3.05) but not 
in longitudinal analyses. Clinical and behavioral risk factors mostly explained the observed 
associations and interactions.  
 
Conclusions: A high GRS combined with a low SEP provides the highest risk for T2DM. These 
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measures should target individual and contextual factors of this high-risk group to reduce the risk 
of T2DM. 
 
Key words: genetic predisposition, genetic risk score, socioeconomic position, socioeconomic 
status, type 2 diabetes mellitus, interaction 
 
Abbreviations: ATC – Anatomical therapeutic chemical; BMI – Body mass index; CI – 
Confidence interval; DPB – Diastolic blood pressure; FPG – Fasting plasma glucose; GRS – 
Genetic risk score; GWAS – Genome-wide association study; HbA1c – glycated hemoglobin; 
HR – Hazard ratio; OR – Odds ratio; PC – Principal component score; RERI – Relative excess 
risk due to interaction; SBP – Systolic blood pressure; SD – Standard deviation; SEP – 
Socioeconomic position; SNP – Single-nucleotide polymorphism; T2DM – Type 2 diabetes 
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Introduction 
Type 2 diabetes mellitus (T2DM) is a common chronic health condition affecting hundreds of 
millions of people worldwide (1). In 2014, the estimated global prevalence was 9.0% for adult 
men and 7.9% for adult women (1) T2DM results in a high number of disability adjusted life 
years, and is a major risk factor for other diseases like cardiovascular disease and chronic kidney 
disease (2-5) Evidence on T2DM is extensive, but still lacks on the interaction between genetic 
and environmental factors in the etiology of the disease. This evidence is essential to 
successfully tackle this major public health problem.  
 
Low socioeconomic position (SEP) is a well-known risk factor for T2DM (6). A 
systematic review and meta-analysis, including 23 studies with 41 measures of association 
between low SEP and T2DM incidence, found that low SEP, measured as low educational level, 
low occupational status, and low income, was associated with increased relative risks for T2DM 
in high, middle, and low income countries (6) The association between low SEP and T2DM is 
probably due to a high prevalence of clinical and behavioral risk factors, such as obesity and 
physical inactivity, among people with a low SEP (7-10) often in co-occurrence (11-13) These 
risk factors are potentially modifiable. 
 
Genetic and environmental factors have been shown to interact in the etiology of T2DM 
(14) Regarding SEP and genetic predisposition, one might expect that the negative effects of low 
SEP on T2DM are aggravated by a strong genetic predisposition through the interplay of 
genetics and environmental risk factors associated with low SEP (15). This genetic 
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SNPs associated with T2DM (16) If people are not genetically predisposed to the disease i.e. in 
case of a low GRS, low SEP may have little or no effect.  
 
To our knowledge, only one study investigated the interaction between a GRS and SEP 
regarding T2DM (15) This study showed that the effect of strong genetic predisposition on 
HbA1c levels was smaller among people with a higher educational level (15) Studies on specific 
behavioral and clinical risk factors showed that obesity and a Western dietary pattern (i.e. high 
intake of red and processed meats and refined foods) interact with genetic predisposition in the 
etiology of T2DM (17-19) However, evidence lacks on the influence of genetic predisposition on 
the overarching effect of low SEP in the etiology of T2DM.  
 
The aggravating or buffering effect of a strong or weak genetic predisposition on the 
effect of low SEP in the etiology of T2DM may also differ by sex, e.g. due to differences in 
metabolic homeostasis (20)It was previously found that family history of T2DM and low SEP 
exacerbated each other’s impact in females but not in males (21) Because possible sex 
differences may be important for the design of future prevention and intervention strategies, they 
need to be taken into account.   
 
 Therefore, the main aims of this study are to examine associations and interactions of a 
GRS and SEP with T2DM, and to investigate whether clinical and behavioral risk factors can 
explain these associations and interactions. Possible effect modification by sex will be taken into 
account in the analyses. We will perform cross-sectional and longitudinal analyses to examine 
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Biobank Study. We hypothesize that having both a high GRS and a low SEP results in an excess 
risk for T2DM, and that behavioral and clinical risk factors partly explain this interaction.  
 
Methods 
Study design and sample 
The study sample was derived from the Lifelines Cohort and Biobank Study (22) Lifelines is a 
multi-disciplinary prospective population-based cohort study examining the health and health-
related behaviors of 167,729 persons living in the north of The Netherlands. Between November 
2006 and December 2013, individuals were invited through their general practitioner or a family 
member, and there was an option for self-registration. The recruitment and collection of data 
have been described in detail elsewhere (22) 
 
For the present study, we used participants who were genotyped at baseline (n=13,395) 
on whom phenotypic data were obtained from the baseline measurement, from two follow-up 
questionnaires after approximately 1.5 and 3 years, and from a physical follow-up measurement 
after 5 years. The selection and genotyping of this sub-sample has been described in detail 
elsewhere (23) with the only difference that we used 1000 Genomes imputation instead of 
HapMap. Lifelines was conducted according to the guidelines in the Declaration of Helsinki and 
all procedures involving human subjects were approved by the Medical Ethics Committee of the 
University Medical Center Groningen. Written informed consent was obtained from all 
participants. 
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Measures and procedures 
Type 2 diabetes mellitus (T2DM) 
The presence of T2DM was determined at four measurement points. At baseline, T2DM was 
diagnosed as having a measured fasting plasma glucose (FPG) ≥7.0 mmol/L (24) and/or a 
measured HbA1c ≥6.5% (48 mmol/mol) (24) and/or recorded medication use (i.e. anatomical 
therapeutic chemical (ATC) codes A10A and A10B) (25) and/or self-reported T2DM in 
combination with self-reported medication use. For the follow-up after 1.5 and 3 years, T2DM 
diagnosis was based on self-reported new onset of the disease. At the physical follow-up after 5 
years, T2DM was diagnosed based on FPG, HbA1c and on self-reported disease. T2DM 
diagnosis, which does not include type 1 DM cases, and blood value measurements have been 




Socioeconomic position (SEP) was measured as educational level at baseline. Educational level 
has been shown to be a good indicator to study socioeconomic health inequalities in the 
Netherlands (28). In addition, the proportion of missing data is usually small compared to other 
indicators of SEP (29). Educational level was measured according to the International Standard 
Classification of Education with a single-item question regarding the highest educational level 
achieved (30). Educational level was categorized into low (no education, primary education, 
lower or preparatory vocational education, lower general secondary education), medium 
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or pre-university secondary education), and high SEP (higher vocational education, university), 
which is the standard categorization of educational level in the Netherlands (31). 
 
Genetic predisposition 
To determine participants’ genetic predisposition to T2DM, we selected single-nucleotide 
polymorphisms (SNPs) from the most recent large meta-analysis of genome-wide association 
studies (GWAS) in European populations (32) supplemented with more recent findings from the 
same consortium (33-35) Only SNPs with a p-value below the genome-wide significance 
threshold (p< 5 x 10
-8
) were included. If two papers reported the same marker, the result with the 
smallest p-value was selected. Furthermore, we tested for independence by correlating the allele 
dosages within Lifelines. If the pairwise r
2
 value of two SNPs exceeded 0.1, we excluded the 
SNP with the least significant p-value. For each selected SNP, we collected the alleles, risk-allele 
frequency, odds ratio (OR) and p-value. See Supplementary Table 1 (Supplemental Digital 
Content, http://links.lww.com/PSYMED/A441) for the selected SNPs (n=63) and effect sizes. 
 
Participants’ genetic predisposition to T2DM was assessed by calculating a weighted 
genetic risk score (GRS) from ORs obtained from the above mentioned GWAS. First, we log-
transformed the ORs to acquire a direct effect-size for each SNP. For each SNP in each 
participant, we then multiplied the effect-size with the number of risk alleles of that SNP. 
Adding up these values per participant for all 63 SNPs yields the weighted GRS of that 
participant. Because there are no clear cut-off points for defining low or high genetic risk, we 
created three equal groups (i.e. low, medium, or high genetic predisposition for T2DM). This 
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Behavioral and clinical risk factors 
Behavioral and clinical risk factors were measured at baseline and concerned smoking, alcohol 
consumption, physical activity, body mass index (BMI), waist circumference (WC), and 
hypertension. Smoking status was categorized as being a current smoker, ex-smoker, or never 
smoker (36) Alcohol consumption was categorized into drinking 0 days/week, drinking 0-1 
days/week, drinking >1 to 3 days/week and drinking >3 days/week. Because information on the 
average number of units consumed on a drinking day was not available for half of our study 
sample (i.e. the question was not included in early versions of the questionnaire), we could not 
specify alcohol consumption any further. Physical activity was based on the number of days per 
week participants were active for at least half an hour (e.g. bicycle, odd jobs, exercise) and was 
categorized into being inactive (0-2 days per week), moderately active (3-4 days per week), or 
active (≥5 day per week). BMI was calculated as weight (kg) divided by height (m) squared and 
used as an index of general weight status. Participants were categorized as having underweight 
(BMI <18.5), normal weight (BMI ≥18.5 - ≤24.9), overweight (BMI ≥25.0 - ≤29.9) or obesity 
(BMI ≥30.0) (37) WC was measured to the nearest 0.5 centimeter and used as an index for 
abdominal obesity. Participants were categorized as not having abdominal obesity (WC <102 cm 
in males, WC <88 cm in females) and having abdominal obesity (WC ≥102 cm in males, WC 
≥88 cm in females) (37) Hypertension diagnosis was based on measured blood pressure and 
recorded medication use. A mean systolic and diastolic blood pressure (SBP and DBP, 
respectively) were measured using an automatic blood pressure monitor (22) Participants with a 
BP >140/90 mm Hg (38) and participants with recorded antihypertensive medication (i.e. ATC 
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in Lifelines (26). Clinical measurements were performed by trained research staff using 
standardized protocols and calibrated measuring equipment (22) 
 
Statistical analyses 
First, we created a variable in which we categorized participants into 9 possible groups according 
to their GRS and SEP. We then described baseline characteristics concerning socio-
demographic, behavioral and clinical risk factors. We also calculated the overall baseline 
prevalence and 5-year incidence of T2DM.  
 
Second, we assessed cross-sectional and longitudinal associations of GRS and SEP with 
T2DM using logistic regression models and Cox regression models, respectively. Odds ratios 
(OR) and Hazard ratios (HR) with 95% confidence intervals (CI) were calculated for each 
category of GRS and SEP, with the reference category being low GRS and high SEP (39) All 
analyses were adjusted for age, age-squared, sex and the first 10 principal component scores 
(PCs). Adjusting analyses for the first 10 PCs is common practice to correct for possible 
population stratification in studies using genotypic data (40) In the longitudinal analysis, we 
excluded participants with T2DM at baseline. Effect modification of sex was examined by 
adding an interaction term to the cross-sectional and longitudinal models. Because no effect 
modification was observed in the cross-sectional (p = 0.65) or longitudinal (p = 0.61) models, 
analyses were not stratified by sex. 
 
Third, we assessed the interaction of GRS and SEP regarding T2DM on the additive scale 





Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
longitudinal analyses. The RERI shows whether the risk for T2DM is larger than the sum of the 
separate risks when both risk factors are present. The additive scale has been shown to best fit 
the method for assessing biological interaction in previous studies (39,41,42) Analyses were 
performed using the recommended syntax and Excel tool by Andersson et al (43). To gain 
further insight, we also examined associations between SEP and T2DM within categories of 
GRS; and between GRS and T2DM within categories of SEP (39)  
 
Fourth, to examine whether behavioral and clinical risk factors explain the associations 
and interactions of GRS and SEP with T2DM, we adjusted the basic model stepwise for 
behavioral and clinical risk factors at baseline. In model 1, we adjusted for smoking status, 
alcohol consumption, and physical activity. In model 2, we added general weight status and 
abdominal obesity. In model 3, we included hypertension. Participants with missing data on 
clinical and behavioral risk factors were excluded from these analyses. In the final cross-
sectional and longitudinal models, 13.0% and 11.7% had missing data, respectively. This was 
mainly due to missing data on physical activity (9.1% and 7.9%), smoking status (4.3% and 
4.1%), and alcohol use (2.1% and 1.2%). Data on clinical risk factors was mostly complete (i.e.7 
(0.1%) and 6 (0.1%) missing values).  
 
We performed two sensitivity analyses. First, we repeated the second and third step of the 
analyses using household income instead of educational level as indicator for SEP. Second, we 
repeated the second and third step of the analyses using quartiles instead of tertiles for the GRS.  
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Results 
Baseline characteristics 
In total, 13,027 and 11,756 participants were included in the cross-sectional and longitudinal 
analyses, respectively (Supplementary Figure 1, Supplemental Digital Content, 
http://links.lww.com/PSYMED/A441). Baseline characteristics of the cross-sectional study 
sample are shown by GRS and SEP in Table 1. Participants with a low SEP, regardless of GRS, 
tended to be older than participants with a medium or high SEP. They were also more often 
obese, smoker, and had a higher prevalence of hypertension compared to participants with a 
medium or high SEP. Baseline characteristics of the longitudinal study sample were essentially 
similar (Supplementary Table 2, Supplemental Digital Content, 
http://links.lww.com/PSYMED/A441). T2DM prevalence increased with an increasing GRS and 
decreasing SEP, and was highest for participants with a high GRS and low SEP (8.2%) (Figure 
1). T2DM incidence followed a similar pattern but differences between categories were less 
pronounced. The median follow-up time for the longitudinal study sample was 57.0 months (25
th
 
– 75th percentile: 47.0 – 68.0 months). The overall prevalence of T2DM was 3.9% at baseline 
and the overall incidence during 5-year follow-up was 2.2%. Information about the distribution 
of the GRS is presented in Supplementary Table 3 and Supplementary Figure 2 (Supplemental 
Digital Content, http://links.lww.com/PSYMED/A441). 
 
Associations and interactions of GRS and SEP with T2DM 
In the cross-sectional analyses, we found statistically significant associations for a high GRS 
with a low, medium, and high SEP, and for having a medium GRS with medium or low SEP 
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3.84; 95% CI: 2.28, 6.46). We found statistically significant interactions between a high GRS 
and a low SEP (RERI: 1.85; 95% CI: 0.65, 3.05), and between a medium GRS and a low and 
medium SEP (Table 2). No interaction was observed between a high GRS and medium SEP.  
 
In the longitudinal analyses, statistically significant associations of GRS and SEP with 
T2DM were observed for a high GRS with a low or medium SEP, and a medium or low GRS in 
combination with a low SEP (Table 2). The HR for T2DM was highest for participants with a 
high GRS and a low SEP (HR: 2.71; 95% CI: 1.39, 5.27). No statistically significant interaction 
was found between GRS and SEP. 
 
Stratified analyses for T2DM within categories of GRS and SEP 
The upper part of Table 3 shows the association of SEP with T2DM within categories of GRS. In 
the cross-sectional analyses, low and medium SEP were associated with increased odds for 
T2DM for participants with a medium and high GRS, but not for participants with a low GRS. In 
the longitudinal analyses, low and medium SEP were associated with T2DM for participants 
with a high GRS. Moreover, low SEP was associated with T2DM for participants with a low, but 
not medium, GRS. 
 
The bottom part of Table 3 shows the association of GRS with T2DM within categories 
of SEP. In the cross-sectional analyses, a high GRS was associated with higher odds for T2DM 
across all categories of SEP, while a medium GRS was associated with increased odds for T2DM 
in participants with a medium and low SEP. In the longitudinal analyses, a high or medium GRS 
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The role of clinical and behavioral risk factors in the association and interaction of GRS and 
SEP with T2DM 
Clinical and behavioral risk factors partly explained the associations and interactions of GRS and 
SEP with T2DM in the cross-sectional analyses (Table 4). After their inclusion, a high GRS was 
still associated with T2DM across all categories of SEP. A statistically significant interaction 
between a high GRS and a low SEP was still observed after adjustment for smoking status, 
alcohol consumption, and physical activity (RERI: 1.20; 95% CI: 0.07, 2.32) (Model 1) but no 
longer after additional adjustment for weight status (model 2). In the longitudinal analyses, only 
a high GRS for participants with a medium SEP was still associated with T2DM after adjustment 
for all clinical and behavioral risk factors (HR: 2.37; 95% CI: 1.13, 4.97) (model 3). 
 
Sensitivity analyses 
The first sensitivity analysis showed that associations between SEP and T2DM were somewhat 
stronger when using household income as indicator for SEP (Supplementary Table 4, 
Supplemental Digital Content, http://links.lww.com/PSYMED/A441). However, the interaction 
effect was smaller. The second sensitivity analysis showed that categorizing the GRS into 
quartiles yields very similar results (Supplementary Table 5, Supplemental Digital Content, 
http://links.lww.com/PSYMED/A441). The point estimates for T2DM for those in the highest 
GRS quartile became a bit larger at the expense of precision. 
 
Discussion 
In this study of over 13,000 Dutch adults from the general population, we found in both cross-
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highest risk for T2DM compared to participants with a low GRS and a high SEP. In addition, a 
high GRS and a low SEP exacerbated each other’s impact in cross-sectional but not in 
longitudinal analyses. Clinical and behavioral risk factors mostly explained the associations and 
interactions of a high GRS and a low SEP on T2DM. 
 
A major strength of this study is that T2DM diagnosis, depending on the measurement 
point, was based on biological markers (FPG and HbA1c), on recorded medication use, and on 
self-reports in a population-based study sample. In addition, the clinical risk factors general 
obesity, abdominal obesity, and hypertension were measured by trained research staff. Finally, 
the GRS was based on the most recent GWAS findings in individuals from European ancestry 
including only SNPs that were genome-wide significantly associated with T2DM. However, this 
study also has some limitations that warrant attention. The 5-year follow-up period (median: 57.0 
months; 25
th
 – 75th percentile: 47.0 – 68.0 months) is relatively short for demonstrating 
interaction, maybe leading to an underestimation of the full effects. This was supported by a 
post-hoc power calculation showing a power of 26.6% to detect interaction in the longitudinal 
analyses. Larger studies or studies pooling several data-sets, with a longer follow-up period, are 
needed to compensate for the low incidence. We further had some missing data in the model 
adjusted for all clinical and behavioral risk factors, implying that their explanatory effect may be 
slightly larger in particular regarding alcohol consumption.  
 
We demonstrated that a high GRS and a low SEP were separately associated with T2DM, 
which confirms findings from previous studies (6,44-46) We further showed that these risk 
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was recently found for family history of T2DM as indicator for genetic predisposition, although 
only for women (21) In the longitudinal analyses, we did not find an interaction between a high 
GRS and low SEP, on top of their separate effect. This contrasts with previous findings that the 
effect of genetic risk on HbA1c levels is smaller among people with a higher educational level 
(15) An explanation may be our shorter follow-up period (i.e. 5 vs. 18 years) and our younger 
study sample (i.e. mean: 48.1 years (SD: 11.4) versus 64% aged >65 (mean not presented)).  
 
There were two noteworthy differences between the findings from the cross-sectional and 
longitudinal analyses. First, a high GRS was more strongly associated with T2DM in the cross-
sectional than in the longitudinal analyses. The effect of a high GRS may have already come to 
expression cross-sectionally while more time might be needed to lead to effects in the longer 
term. Second, while low SEP was not cross-sectionally associated with T2DM in participants 
with a low GRS, a strong association between low SEP and T2DM in participants with a low 
GRS was found in longitudinal analyses. This contradictory finding deserves attention in future 
studies because the cross-sectional results suggest that a weak genetic predisposition may buffer 
the negative effect of low SEP.   
 
We found that the interaction between a high GRS and a low SEP was partly explained 
by clinical and behavioral risk factors. In general, most T2DM cases can be attributed to dietary 
habits, physical inactivity, smoking, alcohol consumption and overweight or obesity (47,48) and 
previous studies have shown that these and other risk factors mediate the relationship between 
low SEP and T2DM (7-10) This may be due to underlying factors that are associated with low 
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interpretation and translation of information about risk factors into healthy behavior (49) Low 
health literacy may then contribute largely to the development of diseases with a major 
behavioral component, like T2DM. 
 
Our findings regarding educational level and household income as indicators for SEP 
were largely similar. Results might differ somewhat in magnitude when other indicators of SEP 
are used (e.g. occupational status). However it is likely that the main conclusions would be 
similar, since all indicators for SEP measure underlying social stratification (29). For T2DM 
specifically, this is illustrated by a systematic review and meta-analysis on the relation between 
SEP and T2DM incidence (6). This review showed that the relative risk for T2DM was similar 
for low educational level, low occupational status, and low income. In practical terms, in care 
settings it is easier and will evoke less resistance to assess people’s educational level than 
income, because income is often considered private information. 
 
Findings from this study may have some important implications for clinical practice and 
research. Prevention and intervention strategies aimed at reducing T2DM incidence should target 
people with a strong genetic predisposition for the disease, especially in the context of a low 
SEP. This may regard genotyping or family history as its proxy as long as genotyping is not 
generally available (21,50) These strategies should address individual and contextual factors (51) 
Individual factors should definitely include health behaviors like physical inactivity and obesity 
(7,8) and potentially contributing factors such as low health literacy (49) Contextual factors 
should include, for example, the built environment, which has shown to be important for the 
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Our cross-sectional findings further suggest that low SEP does not have a detrimental 
effect regarding T2DM in case of a low GRS. This might imply that prevention measures do not 
need to target individuals with a low SEP and weak genetic predisposition, but evidently this 
requires additional study. Future studies should also examine factors contributing to the 
interaction between strong genetic predisposition and low SEP, such as dietary habits and the 
physiologic response to chronic stress related to low SEP as they may play an important role in 
T2DM etiology (11,53). Future research may also need to investigate the role of sleep behavior 
since several genes have been found to affect both sleep behavior and the risk for T2DM (54). 
Finally, because our findings are based on people of European ancestry, future studies need to 
examine whether results are generalizable to other ethnic groups with a different genetic 
predisposition to T2DM (11) 
 
 We conclude that the co-occurrence of a high GRS and low SEP is associated with 
T2DM prevalence and 5-year incidence. We further conclude that a high GRS and a low SEP 
exacerbate each other’s impact regarding T2DM prevalence but we could not replicate this 
finding for T2DM incidence. Finally, we conclude that clinical and behavioral risk factors 
mostly explained the associations and interactions of a high GRS and a low SEP on T2DM. The 
exacerbation by low SEP of T2DM risk in genetically predisposed people therefore deserves 
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Figure captions 
 
Figure 1 Baseline prevalence and 5-year incidence of type 2 diabetes mellitus across 
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Table 1 Baseline characteristics of the cross-sectional study sample 
 
 Low GRS Medium GRS High GRS 


















Age, y (mean, SD) 45.5 (10.5) 45.3 (10.1) 52.3 (11.4) 46.4 (11.2) 45.3 (10.0) 51.9 (11.8) 46.1 (10.7) 44.9 (10.3) 52.1 (11.7) 
Gender (% F) 53.4 59.6 61.7 52.4 59.6 58.1 51.3 60.7 60.3 
Smoking (%)          
   Non-smoker 51.3 47.5 37.6 52.3 46.7 40.0 51.7 48.5 39.4 
   Former smoker 30.1 28.7 34.4 31.6 29.9 31.4 31.0 27.7 31.4 
   Current smoker 18.6 23.9 28.0 16.0 23.4 28.7 17.2 23.8 29.2 
Alcohol consumption (%)          
   0 days per week 26.4 35.5 34.1 26.6 33.9 37.7 25.5 34.0 36.4 
   0-1 days per week 16.3 17.6 17.5 17.2 18.1 15.7 19.2 18.7 16.4 
   1-3 days per week 35.0 30.9 27.6 32.2 30.5 27.0 31.7 29.7 29.6 
   >3 days per week 22.2 16.0 20.8 24.0 17.4 19.5 23.6 17.6 17.7 
Physical activity (%)          
   Active 55.8 53.2 53.5 53.0 50.2 53.8 53.3 54.5 55.4 
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   Inactive 20.1 22.7 24.9 22.0 24.7 25.0 20.2 22.9 24.0 
Body mass index (mean, SD) 25.3 (3.8) 26.2 (4.5) 27.1 (4.4) 25.4 (3.6) 26.3 (4.4) 27.1 (4.5) 25.6 (3.7) 26.4 (4.2) 26.9 (4.2) 
General obesity (%)          
   Underweight 0.4 0.7 0.8 0.4 0.4 0.3 0.9 0.3 0.7 
   Normal weight 50.1 43.5 33.3 49.3 41.7 32.6 45.9 40.4 33.4 
   Overweight 39.4 40.2 45.0 41.0 41.9 44.6 40.9 43.2 45.7 
   Obese 10.1 15.7 21.0 9.3 16.0 22.6 12.2 16.1 20.1 
WC, cm F (mean, SD) 85.2 (11.3) 87.7 (12.9) 90.7 (12.0) 84.7 (10.6) 88.1 (12.3) 91.4 (12.7) 85.6 (11.0) 88.2 (11.6) 90.5 (12.1) 
WC, cm M (mean, SD) 93.7 (9.4) 95.9 (10.4) 98.9 (11.2) 94.7 (9.1) 95.9 (10.4) 98.6 (10.7) 95.7 (10.1) 96.6 (10.6) 98.3 (10.4) 
Abdominal obesity (%) 28.3 36.9 49.9 28.2 38.7 49.8 32.8 39.2 47.6 
SBP, mm Hg (mean, SD) 125.8 (14.7) 127.2 (15.3) 131.0 (16.1) 126.3 (15.1) 127.0 (15.2) 131.0 (15.9) 126.8 (15.1) 126.8 (14.9) 132.0 (17.4) 
DBP, mm Hg (mean, SD) 74.8 (9.1) 74.8 (9.1) 76.2 (9.2) 74.7 (8.7) 75.0 (8.9) 76.2 (9.0) 75.0 (9.2) 74.7 (8.7) 76.2 (9.4) 
Hypertension (%) 22.2 25.2 39.0 23.1 26.5 40.8 26.0 25.9 40.3 
 
Abbreviations: GRS: genetic risk score; SEP: socioeconomic position; SD: standard deviation; WC: waist circumference; SBP: 
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Table 2 Associations and interactions of GRS and SEP with T2DM 
 
  n T2DM / n total OR (95% CI) RERI (95% CI) 
Cross-sectional    
Low GRS    
   High SEP 17/1,118 1.00 (ref)  
   Medium SEP 28/1,630 1.24 (0.67, 2.29)  
   Low SEP 43/1,596 1.13 (0.64, 2.02)  
Medium GRS    
   High SEP 30/1,142 1.58 (0.86, 2.90)  
   Medium SEP 61/1,582 2.91 (1.68, 5.04) 1.15 (0.06, 2.24)
a
 
   Low SEP 105/1,619 2.89 (1.71, 4.91) 1.29 (0.32, 2.26)
b
 
High GRS    
   High SEP 36/1,169 1.96 (1.08, 3.53)  
   Medium SEP 62/1,565 3.03 (1.75, 5.25) 0.91 (-0.28, 2.11)
a
 
   Low SEP 132/1,606 3.84 (2.28, 6.46) 1.85 (0.65, 3.05)
b
 
    
Longitudinal n T2DM / n total HR (95% CI) RERI (95% CI) 
Low GRS    
   High SEP 11/1,055 1.00 (ref) 
 
   Medium SEP 23/1,511 1.57 (0.77, 3.23) 
 
   Low SEP 43/1,444 2.37 (1.21, 4.61) 
 
Medium GRS   
 
   High SEP 18/1,063 1.56 (0.73, 3.30) 
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   Low SEP 43/1,396 2.56 (1.31, 4.99) -0.41 (-1.95, 1.13)
b 
High GRS   
 
   High SEP 18/1,075 1.46 (0.69, 3.09) 
 
   Medium SEP 35/1,428 2.66 (1.35, 5.24) 0.70 (-0.66, 2.05)
a 
   Low SEP 44/1,357 2.71 (1.39, 5.27) -0.12 (-1.55, 1.32)
b 
 
Abbreviations: GRS: genetic risk score; SEP: socioeconomic position; T2DM: type 2 diabetes 
mellitus: OR: odds ratio; CI: confidence interval; RERI: relative excess risk due to 
interaction; HR: Hazard ratio 
 
ORs/HRs are adjusted for age, age-squared, gender, and principal component scores 
a
 RERI T2DM for medium SEP; 
b 
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Table 3 Associations per category of SEP and GRS with T2DM 
 
 Cross-sectional Longitudinal 
 OR (95% CI) HR (95% CI) 
The association of SEP and  
T2DM per category of GRS 
  
Low GRS   
   High SEP 1.00 (ref) 1.00 (ref) 
   Medium SEP 1.26 (0.68, 2.33) 1.56 (0.75, 3.21) 
   Low SEP 1.32 (0.73, 2.38) 2.40 (1.22, 4.75) 
Medium GRS   
   High SEP 1.00 (ref) 1.00 (ref) 
   Medium SEP 1.81 (1.15, 2.86) 0.90 (0.47, 1.73) 
   Low SEP 1.79 (1.16, 2.76) 1.60 (0.90, 2.83) 
High GRS   
   High SEP 1.00 (ref) 1.00 (ref) 
   Medium SEP 1.59 (1.03, 2.44) 1.87 (1.05, 3.33) 
   Low SEP 1.89 (1.27, 2.82) 1.94 (1.10, 3.43) 
   
The association of GRS and  
T2DM per category of SEP 
  
High SEP   
   Low GRS 1.00 (ref) 1.00 (ref) 
   Medium GRS 1.53 (0.82, 2.84) 1.59 (0.75, 3.39) 
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Medium SEP   
   Low GRS 1.00 (ref) 1.00 (ref) 
   Medium GRS 2.33 (1.47, 3.69) 0.89 (0.48, 1.64) 
   High GRS 2.44 (1.54, 3.87) 1.67 (0.98, 2.82) 
Low SEP   
   Low GRS 1.00 (ref) 1.00 (ref) 
   Medium GRS 2.56 (1.77, 3.69) 1.05 (0.69, 1.61) 
   High GRS 3.39 (2.37, 4.84) 1.12 (0.74, 1.71) 
 
Abbreviations: SEP; socioeconomic position; GRS: genetic risk score; T2DM: type 2 diabetes 
mellitus; OR: odds ratio; CI: confidence interval; HR: hazard ratio 
 
ORs/HRs are adjusted for age, age-squared, gender, and principal component scores
 
 
Note: some categories in this Table are similar to those in Table 2 but ORs/HRs may slightly 
differ because these are result from within category analyses (i.e. different size of the sample 
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Table 4 Adjusted associations and interactions of GRS and SEP with T2DM # 
 
 Cross-sectional Longitudinal 
 OR (95% CI) RERI (95% CI) HR (95% CI) RERI (95% CI) 
Model 1     
Low GRS     
   High SEP 1.00 (ref)  1.00 (ref)  
   Medium SEP 1.15 (0.60, 2.21)  1.80 (0.83, 3.92)  
   Low SEP 0.84 (0.45, 1.59)  2.57 (1.24, 5.35)  
Medium GRS     
   High SEP 1.45 (0.76, 2.79)  1.66 (0.73, 3.77)  
   Medium SEP 2.35 (1.30, 4.27) 0.83 (-0.16, 1.81)
a
 1.38 (0.61, 3.12) -1.08 (-2.99, 0.83)
a
 
   Low SEP 2.32 (1.31, 4.11) 1.09 (0.20, 1.98)
b
 2.79 (1.34, 5.80) -0.60 (-2.39, 1.20)
b
 
High GRS     
   High SEP 2.19 (1.18, 4.07)  1.65 (0.73, 3.74)  
   Medium SEP 2.32 (1.27, 4.23) 0.01 (-1.30, 1.31)
a
 2.92 (1.39, 6.13) 0.46 (-1.11, 2.03)
a
 
   Low SEP 3.10 (1.76, 5.43) 1.20 (0.07, 2.32)
b
 2.68 (1.29, 5.60) -0.60 (-2.38, 1.18)
b
 
     
Model 2     
Low GRS     
   High SEP 1.00 (ref)  1.00 (ref)  
   Medium SEP 1.02 (0.53, 1.97)  1.56 (0.72, 3.39)  
   Low SEP 0.69 (0.36, 1.31)  1.99 (0.95, 4.14)  
Medium GRS     
   High SEP 1.57 (0.81, 3.03)  1.66 (0.73, 3.76)  
   Medium SEP 2.10 (1.15, 3.84) 0.59 (-0.40, 1.57)
a
 1.21 (0.53, 2.74) -0.98 (-2.76, 0.81)
a
 
   Low SEP 1.89 (1.06, 3.38) 0.74 (-0.11, 1.60)
b







Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
High GRS     
   High SEP 2.09 (1.12, 3.91)  1.42 (0.63, 3.23)  
   Medium SEP 2.02 (1.10, 3.71) -0.11 (-1.36, 1.13)
a
 2.46 (1.17, 5.16) 0.59 (-0.69, 1.88)
a
 
   Low SEP 2.65 (1.50, 4.69) 0.95 (-0.07, 1.96)
b
 2.22 (1.06, 4.63) -0.30 (-1.79, 1.19)
b
 
     
Model 3     
Low GRS     
   High SEP 1.00 (ref)  1.00 (ref)  
   Medium SEP 1.00 (0.51, 1.93)  1.48 (0.68, 3.23)  
   Low SEP 0.67 (0.35, 1.27)  1.83 (0.88, 3.81)  
Medium GRS     
   High SEP 1.56 (0.81, 3.02)  1.64 (0.72, 3.72)  
   Medium SEP 2.02 (1.10, 3.69) 0.50 (-0.48, 1.49)
a
 1.16 (0.51, 2.64) -0.99 (-2.77, 0.79)
a
 
   Low SEP 1.76 (0.98, 3.14) 0.65 (-0.20, 1.50)
b
 2.02 (0.97, 4.20) -0.49 (-1.99, 1.01)
b
 
High GRS     
   High SEP 2.06 (1.10, 3.86)  1.37 (0.60, 3.11)  
   Medium SEP 1.97 (1.07, 3.63) -0.09 (-1.33, 1.15)
a
 2.37 (1.13, 4.97) 0.62 (-0.63, 1.86)
a
 
   Low SEP 2.51 (1.42, 4.44) 0.86 (-0.14, 1.85)
b





Model 1: age, age-squared, gender, PCs, smoking, alcohol consumption, physical activity 
Model 2: model 1 plus general weight status, abdominal obesity  
Model 3: model 2 plus hypertension 
Abbreviations: GRS: genetic risk score; SEP: socioeconomic position; T2DM: type 2 diabetes 
mellitus; OR: odds ratio; CI: confidence interval; RERI: relative excess risk due to 
interaction; HR: hazard ratio 
a
 RERI T2DM for medium SEP; 
b
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